TRMT112P5

Across TCGA pan-cancer cohorts, TRMT112P5 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated TRMT112P5 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher TRMT112P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRMT112P5 expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

PAAD, SKCM, and THCA are the cancer types where TRMT112P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.137	0.619	<.001	72	view →
SKCM	DFS	Tertile	All	0.174	0.730	<.001	36	view →
THCA	OS	Tertile	All	0.965	0.990	<.001	36	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
BLCA	DFS	Tertile	All	0.159	0.625	.031	18	view →
STAD	DFS	Tertile	All	0.214	0.564	.002	18	view →
HNSC	OS	Tertile	All	1.000	0.676	.037	9	view →
SARC	DFS	Tertile	All	0.164	0.517	.040	9	view →
LGG	OS	Tertile	All	0.200	0.472	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

TRMT112P5–PAAD (OS)

Open the PAAD breakdown →